Scientific Publications

Characterization of Novel Multiantigenic Vaccine Candidates with Pan-HLA Coverage against Mycobacterium tuberculosis …

TO DOWNLOAD

ImMucin™ A novel therapeutic vaccine with promiscuous MHC binding for the treatment of MUC1 expressing tumors …

TO DOWNLOAD

Phase I/II study exploring ImMucin™ a pan-major histocompatibility complex, anti-MUC1 signal peptide vaccine, in multiple myeloma patients …

TO DOWNLOAD

Autoantibodies against the signal peptide domain of MUC1 in patients with multiple myeloma Implications …

TO DOWNLOAD

Cell Surface-Associated Anti-MUC1-Derived Signal Peptide Antibodies Implications for Cancer Diagnostics and Therapy …

TO DOWNLOAD

The use of signal peptide domains as vaccine candidates …

TO DOWNLOAD